» Articles » PMID: 9794707

Orally Effective Iron Chelators for the Treatment of Iron Overload Disease: the Case for a Further Look at Pyridoxal Isonicotinoyl Hydrazone and Its Analogs

Overview
Journal J Lab Clin Med
Publisher Elsevier
Date 1998 Oct 30
PMID 9794707
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Encapsulation and Biological Activity of Hesperetin Derivatives with HP-β-CD.

Sykula A, Bodzioch A, Nowak A, Maniukiewicz W, Scieszka S, Piekarska-Radzik L Molecules. 2023; 28(19).

PMID: 37836736 PMC: 10574185. DOI: 10.3390/molecules28196893.


3-Chloro-'-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy.

Sarno F, Papulino C, Franci G, Andersen J, Cautain B, Melardo C Front Pharmacol. 2018; 9:1006.

PMID: 30245629 PMC: 6137965. DOI: 10.3389/fphar.2018.01006.


A multifunctional, light-activated prochelator inhibits UVA-induced oxidative stress.

Franks A, Wang Q, Franz K Bioorg Med Chem Lett. 2015; 25(21):4843-4847.

PMID: 26152427 PMC: 4607636. DOI: 10.1016/j.bmcl.2015.06.048.


Potent antimycobacterial activity of the pyridoxal isonicotinoyl hydrazone analog 2-pyridylcarboxaldehyde isonicotinoyl hydrazone: a lipophilic transport vehicle for isonicotinic acid hydrazide.

Ellis S, Kalinowski D, Leotta L, Huang M, Jelfs P, Sintchenko V Mol Pharmacol. 2013; 85(2):269-78.

PMID: 24243647 PMC: 6067633. DOI: 10.1124/mol.113.090357.


Anti-plasmodial activity of aroylhydrazone and thiosemicarbazone iron chelators: effect on erythrocyte membrane integrity, parasite development and the intracellular labile iron pool.

Walcourt A, Kurantsin-Mills J, Kwagyan J, Adenuga B, Kalinowski D, Lovejoy D J Inorg Biochem. 2013; 129:43-51.

PMID: 24028863 PMC: 3838870. DOI: 10.1016/j.jinorgbio.2013.08.007.